Abstract
Voriconazole is a newer systemic antifungal agent effective against Candida and Aspergillus. There are few reports of its safe use in newborns. We report the first case series of safe Voriconazole use in critically ill newborns with cardiac disease along with several other cardiac drugs without any significant drug interaction or side-effect.
MeSH terms
-
Antifungal Agents / adverse effects
-
Antifungal Agents / therapeutic use*
-
Aspergillosis / drug therapy*
-
Aspergillus / drug effects*
-
Candida / drug effects*
-
Candidiasis / drug therapy*
-
Critical Illness
-
Humans
-
Infant, Newborn
-
Pyrimidines / adverse effects
-
Pyrimidines / therapeutic use*
-
Triazoles / adverse effects
-
Triazoles / therapeutic use*
-
Voriconazole
Substances
-
Antifungal Agents
-
Pyrimidines
-
Triazoles
-
Voriconazole